Akebia Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2014 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Akebia Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2014 to Q2 2024.
  • Akebia Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 5, 2024 was 210M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 210M Aug 5, 2024 10-Q 2024-08-08
Q1 2024 209M +23.4M +12.6% Mar 13, 2024 10-K 2024-03-14
Q3 2023 188M +4.35M +2.37% Aug 25, 2023 10-Q 2023-08-28
Q1 2023 186M +2.4M +1.31% Apr 30, 2023 10-Q 2023-05-08
Q3 2022 184M +9M +5.15% Oct 31, 2022 10-Q 2022-11-03
Q2 2022 184M +9.31M +5.34% Jul 31, 2022 10-Q 2022-08-04
Q1 2022 184M +23.4M +14.6% Apr 30, 2022 10-Q 2022-05-09
Q3 2021 175M +30.4M +21% Oct 31, 2021 10-Q 2021-11-04
Q2 2021 175M +31.2M +21.8% Jul 30, 2021 10-Q 2021-08-05
Q1 2021 160M +29.8M +22.9% Apr 30, 2021 10-Q 2021-05-10
Q3 2020 145M +25.6M +21.5% Oct 30, 2020 10-Q 2020-11-05
Q2 2020 143M +24.5M +20.6% Jul 31, 2020 10-Q 2020-08-10
Q1 2020 130M +13.1M +11.2% Apr 30, 2020 10-Q 2020-05-05
Q3 2019 119M +61.9M +108% Oct 31, 2019 10-Q 2019-11-12
Q2 2019 119M +61.8M +108% Jul 31, 2019 10-Q 2019-08-08
Q1 2019 117M +60.2M +106% Mar 15, 2019 10-K 2019-03-26
Q3 2018 57.1M +9.79M +20.7% Oct 31, 2018 10-Q 2018-11-08
Q2 2018 57M +9.89M +21% Jul 31, 2018 10-Q 2018-08-08
Q1 2018 56.9M +18M +46.4% Apr 30, 2018 10-Q 2018-05-09
Q3 2017 47.3M +8.94M +23.3% Oct 31, 2017 10-Q 2017-11-08
Q2 2017 47.2M +9.14M +24% Jul 31, 2017 10-Q 2017-08-08
Q1 2017 38.9M +887K +2.33% Apr 30, 2017 10-Q 2017-05-09
Q3 2016 38.3M +7.69M +25.1% Oct 31, 2016 10-Q 2016-11-09
Q2 2016 38M +9.13M +31.6% Jul 31, 2016 10-Q 2016-08-08
Q1 2016 38M +9.14M +31.7% Apr 30, 2016 10-Q 2016-05-05
Q3 2015 30.6M +10.3M +50.6% Nov 5, 2015 10-Q 2015-11-09
Q2 2015 28.9M +8.62M +42.5% Jul 31, 2015 10-Q 2015-08-11
Q1 2015 28.8M +8.57M +42.3% May 1, 2015 10-Q 2015-05-11
Q3 2014 20.3M Oct 31, 2014 10-Q 2014-11-10
Q2 2014 20.3M Jul 31, 2014 10-Q 2014-08-11
Q1 2014 20.3M Apr 30, 2014 10-Q 2014-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.